DKK1 and gastric cancer: DKK-1, 15 μmol/L Wnt/β-catenin signal pathway inhibitor, was added to gastric cancer cells for 48 h to detect cell proliferation and apoptosis, as well as Wnt2, p-GSK-3β, and β-catenin protein expressions.